Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Künstliche-Intelligenz-gesteuerte versus manuelle CBCT-Planung für Sofortimplantatplatzierung (AI)

27. September 2026 aktualisiert von: Mihad Ibrahim, Shalash Dental education

Künstliche-Intelligenz-gesteuerte versus manuelle CBCT-Planung für sofortige Implantatplatzierung in Molaren-Extraktionsstellen: Eine randomisierte kontrollierte Studie

This study evaluates whether artificial intelligence (AI)-based analysis of cone-beam computed tomography (CBCT) scans can support clinical decision-making for immediate dental implant placement in molar extraction sites.

When a molar tooth is removed, placing a dental implant immediately may reduce treatment time and preserve surrounding bone. However, immediate implant placement is not always possible and depends on the anatomy of the extraction socket, particularly the interradicular septum (the bone between the roots). CBCT imaging is routinely used to assess this anatomy before surgery. Traditionally, radiologists manually evaluate these scans. Recently, AI-based tools have been developed to automatically analyze CBCT images.

In this randomized controlled trial, patients requiring molar extraction and potential immediate implant placement will be assigned to one of two planning approaches: AI-guided CBCT assessment or conventional manual CBCT assessment. The operating surgeon will use the assigned planning report to guide treatment decisions.

The primary outcome of the study is the feasibility of immediate implant placement, defined as successful implant placement with achievement of primary stability during surgery. Secondary outcomes include surgical time, need for changes to the treatment plan, and implant stability measurements.

The goal of this study is to determine whether AI-assisted CBCT analysis performs similarly to, or improves upon, conventional manual radiologic assessment in supporting safe and effective immediate implant placement.

Studienübersicht

Detaillierte Beschreibung

This study is a prospective, parallel-arm, randomized controlled clinical trial designed to evaluate the clinical impact of artificial intelligence (AI)-based CBCT analysis on decision-making for immediate implant placement in molar extraction sites.

Following eligibility confirmation and informed consent, participants requiring molar extraction with potential immediate implant placement will undergo standardized preoperative cone-beam computed tomography (CBCT) imaging. Participants will be randomly allocated in a 1:1 ratio to one of two planning workflows:

AI-guided planning arm: CBCT scans will be analyzed using a pre-specified, locked AI-based segmentation and socket assessment model. The AI system will quantify interradicular septum dimensions and generate a feasibility classification based on predefined anatomical criteria.

Manual planning arm: CBCT scans will undergo conventional manual segmentation and assessment by an experienced radiologist using the same predefined anatomical criteria for feasibility determination.

In both arms, feasibility recommendations will be based on identical, prospectively defined decision thresholds to ensure comparability between planning methods. The operating surgeon will receive only the planning report corresponding to the assigned allocation.

All surgeries will be performed according to a standardized surgical protocol. The primary outcome is intraoperative feasibility of immediate implant placement, defined as successful implant placement in the extraction socket with achievement of primary stability according to prespecified stability criteria documented in the operative record. Cases in which implant placement is not performed or is aborted due to inability to achieve adequate primary stability will be classified as non-feasible.

Secondary outcomes include operative time, need for intraoperative modification of the treatment plan, insertion torque values, and any intraoperative complications.

Outcome assessment will be performed by an independent assessor blinded to allocation. AI analysis will be conducted using a locked model without post hoc modification.

The study aims to determine whether AI-guided CBCT planning is non-inferior or superior to conventional manual CBCT assessment in supporting immediate implant placement decisions.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

80

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Cairo, Ägypten
        • Shalash Implant education

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 99 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Adults≥18 years are able to provide informed consent. Indicated for the extraction of a molar tooth (maxillary or mandibular) with planned implant-supported rehabilitation.
  • Candidate for immediate implant placement attempt based on preoperative clinical evaluation and CBCT availability.
  • Preoperative CBCT will be acquired using the study imaging protocol within a defined window (e.g., ≤4 weeks before surgery).
  • Adequate oral hygiene and periodontal condition compatible with implant surgery (e.g., treated/stable periodontal status per clinician judgement).

Exclusion Criteria:

  • Pregnancy or breastfeeding (due to imaging/surgical considerations).
  • Uncontrolled systemic disease or medical contraindication to oral surgery/implant placement (e.g., uncontrolled diabetes, immunosuppression as judged by clinician).
  • History of head and neck radiotherapy in the implant region. Use of medications associated with compromised bone healing where immediate implant placement is not advised (e.g., high-dose antiresorptives/IV bisphosphonates; you can specify per your clinic policy).
  • Acute uncontrolled infection at the site requiring staged management (e.g., spreading cellulitis/abscess) or other condition precluding immediate placement per surgeon judgement.
  • Need for simultaneous major augmentation that precludes immediate implant placement (e.g., extensive ridge reconstruction planned at the same surgery rather than socket-level grafting).
  • Inadequate CBCT quality for segmentation/measurement (motion artifacts, incomplete field of view, or metal artifact obscuring the septum).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: AI assisted CBCT

Participants randomized to this arm will undergo preoperative cone-beam computed tomography (CBCT) imaging as part of standard diagnostic workup for molar extraction with potential immediate implant placement.

CBCT datasets will be processed using a pre-specified, locked artificial intelligence (AI)-based segmentation and socket assessment model. The AI system will automatically segment the extraction socket anatomy, quantify interradicular septum dimensions, and generate a structured feasibility assessment according to predefined anatomical decision thresholds established in the study protocol.

A standardized AI-generated planning report, including septum measurements and feasibility classification, will be provided to the operating surgeon prior to surgery. The surgeon will use this report to guide preoperative planning and intraoperative decision-making.

Surgical procedures will be performed according to a standardized surgical protocol. Immediate implant placement will be attempte

The intervention consists of a fully automated, deep learning-based CBCT analysis pipeline designed for extraction socket segmentation and quantitative interradicular septum assessment.

The AI system utilizes a pre-trained convolutional neural network architecture to perform voxel-level segmentation of the extraction socket and surrounding alveolar structures on CBCT datasets. Following segmentation, the model automatically quantifies predefined anatomical parameters, including interradicular septum width at standardized reference levels and socket morphology classification. These measurements are generated using algorithmically defined geometric landmarks, ensuring consistent spatial reference across cases.

Feasibility for immediate implant placement is determined using a prespecified, protocol-defined decision rule applied to AI-derived quantitative parameters.

Aktiver Komparator: Manual CBCT segmented

Participants randomized to this arm will undergo preoperative CBCT imaging as part of the standard diagnostic workup for molar extraction with potential immediate implant placement.

CBCT datasets will be evaluated using conventional manual segmentation and radiologic assessment performed by an experienced radiologist. Interradicular septum dimensions and socket morphology will be assessed according to predefined anatomical criteria specified in the study protocol. Feasibility for immediate implant placement will be determined using the same prospectively defined decision thresholds applied in the intervention arm.

A standardized manual planning report, including septum measurements and feasibility classification, will be provided to the operating surgeon before surgery. The surgeon will use this report to guide preoperative planning and intraoperative decision-making.

Surgical procedures will be performed according to the same standardized surgical protocol

The control intervention consists of conventional radiologic evaluation of CBCT datasets using manual segmentation and operator-driven anatomical assessment.

CBCT scans will be reviewed by an experienced oral and maxillofacial radiologist using standard imaging software. Interradicular septum dimensions will be determined through manual identification of anatomical landmarks and measurement using software-based calipers at predefined reference levels. Socket morphology classification will be assigned based on visual interpretation and application of the same predefined anatomical criteria specified in the study protocol.

Feasibility for immediate implant placement will be determined by applying the protocol-defined decision thresholds to manually obtained measurements. All measurements and classifications will be documented in a structured planning report provided to the operating surgeon.

Unlike the AI-guided intervention, this workflow relies on manual landmark identification and ope

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Immediate implant feasability
Zeitfenster: During the implant surgery-intra operative after flap elevation

Proportion of sites with successful immediate implant placement with primary stability at the index surgery (feasible vs not feasible).

During the implant surgery-intra operative after flap elevation

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Planning time (minutes)
Zeitfenster: Preoperative before the surgery

Time to generate the report (AI processing time vs manual segmentation/assessment time).

Preoperative before the surgery

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienleiter: Mahmoud Shalash, PhD, Shalash Implant education

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

3. März 2026

Primärer Abschluss (Tatsächlich)

2. April 2026

Studienabschluss (Tatsächlich)

2. Mai 2026

Studienanmeldedaten

Zuerst eingereicht

1. März 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

6. März 2026

Zuerst gepostet (Tatsächlich)

9. März 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

30. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

27. September 2026

Zuletzt verifiziert

1. März 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 5-9-23

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren